RMTI|EPS $0.15|Rev $69.3M|Net Loss $5.3MRockwell Medical, Inc. is a healthcare company that develops, manufactures, and distributes hemodialysis products to dialysis providers worldwide.
For the full year 2025, the company reported revenue (net sales) of $69.3 million. The basic net loss per share (EPS) for the twelve months ended December 31, 2025, was $(0.15). For the fourth quarter of 2025, revenue was $18.3 million , with a basic net loss per share of $(0.01).
The company achieved a 21% gross margin in the fourth quarter of 2025. Furthermore, Rockwell Medical reported $2.3 million in cash flow from operating activities during the fourth quarter, ending the year with $25.0 million in cash.
This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.